Skip to main content

NIH Director’s Lecture

As part of NIH’s Wednesday Afternoon Lecture Series, the Director’s Lectures feature leading researchers from around the globe. Nominated by scientists and interest groups throughout NIH, the NIH Director specifically approves these annual lectures. There are approximately three NIH Director’s Lectures per year.

The molecular logic of synapse formation in the brain

May 4, 2017 -
3:00pm to 4:00pm
Thomas Christian Südhof, M.D. , Stanford School of Medicine

Thomas Südhof is interested in how synapses form and function in the developing and adult brain. His work focuses on the role of synaptic cell-adhesion molecules in establishing synapses and shaping their properties, on pre- and postsynaptic mechanisms of membrane traffic, and on impairments in synapse formation and synaptic function in neuropsychiatric and neurodegenerative disorders.

Adventures in brain plasticity: from memory palaces to soulcycle

December 7, 2016 -
3:00pm to 4:00pm
Wendy A. Suzuki, Ph.D., New York University

Suzuki’s lab studies the patterns of electrical activity in the brain that underlie our ability to form and retain new long-term memories as well as the effects of physical aerobic exercise to improve a wide of cognitive functions including mood, memory, and attention.

Engineering T cells: moving beyond leukemia

September 28, 2016 -
3:00pm to 4:00pm
Carl June, M.D. , University of Pennsylvania

It is now well established that the immune system can control and eliminate cancer cells. Adoptive T-cell transfer has the potential to overcome the significant limitations associated with vaccine-based strategies in patients who are often immune compromised. Dr. June will discuss how the emerging discipline of synthetic biology—which combines elements of genetic engineering and molecular biology to create new biological structures with enhanced functionalities—can be applied to cancer.

Ancient DNA and the new science of the human past

September 21, 2016 -
3:00pm to 4:00pm
David Reich, D. Phil., Harvard Medical School

Beginning in 2010, it became practical to sequence whole genomes extracted from DNA extracted from ancient human bones, and to analyze the data to understand changes in biology over time. Since then, the amount of ancient DNA data has increased at an extraordinary rate, with the number of samples with at least one-fold genome coverage being five in 2013, 18 in 2014, and 116 in 2015. Dr. Reich will begin his lecture by describing how present-day Europeans derive from a fusion highly divergent ancestral populations as different from each other as are Europeans and East Asians.

Translating the cancer genome: transforming cancer care

March 30, 2016 -
3:00pm to 4:00pm
Elaine R. Mardis, Ph.D. , Washington University School of Medicine

Dr. Mardis has research interests in the application of next-generation sequencing to characterize cancer genomes and transcriptomes, and using these data to support therapeutic decision-making. She also is interested in facilitating the translation of basic science discoveries in cancer into the clinical setting.

Tools for analyzing and repairing complex biological systems

September 2, 2015 -
3:00pm to 4:00pm
Edward Boyden, Ph.D. , Massachusetts Institute of Technology

The goal of the Boyden laboratory is to achieve ground truth understandings of complex biological systems, including entire cells and entire brains, and to use such insights to improve the human condition through novel inventions and therapeutics. To make this possible, Dr. Boyden and his colleagues are currently creating technologies that enable comprehensive observation and control of biological systems, aiming for molecular precision, millisecond resolution, and whole organ scale.

The depressed brain: sobering and hopeful lessons

June 10, 2015
Huda Akil, Ph.D., University of Michigan, Ann Arbor

In her talk, Dr. Akil will discuss the challenges of understanding the pathophysiology of major depressive disorder at the molecular and cellular level and the surprising insights derived from genomics and human postmortem studies. She will describe how animal models and neuroscience studies at multiple levels (from genetic to behaviorial) can be used to test and validate new targets for treatment and/or as biomarkers of the illness.

Inflammation, dysbiosis, and chronic disease

March 18, 2015
Richard Flavell, Ph.D., F.R.S., Yale University

Dysregulation of the immune system and host-microbiota interaction has been associated with the development of a variety of inflammatory as well as metabolic diseases such as obesity and diabetes. Recent studies in Dr. Flavell's laboratory have elucidated the important function of inflammasomes as steady-state sensors and regulators of the gut microbiota. Mice with a disrupted inflammasome pathway have been shown to develop a colitogenic microbial community, which results in exacerbation of chemical-induced colitis and diet-induced steatohepatitis, obesity and type 2 diabetes.

Tracing the Evolution of Adaptive Immunity

February 4, 2015
Max D. Cooper, M.D., Emory University School of Medicine

A search for the origin of our adaptive immune system has revealed that the jawed vertebrates and jawless vertebrates (lampreys and hagfish) use different strategies for generating large repertoires of lymphocyte receptors for antigens.

Skin stem cells in homeostasis, wound-repair and cancer

January 15, 2014
Elaine Fuchs, Ph.D., The Rockefeller University

Typically, the genetic cause of a disease is identified by studying the DNA of affected individuals, finding the responsible gene, and trying to understand how a mutated version might have coded for a defective protein that led to the disease. Dr. Fuchs, however, has pioneered “reverse genetics”: She starts with the protein abnormality and works backwards to identify the human disease. She has applied this strategy to elucidate the genetic basis of a number of blistering skin disorders and tumors.


The page was last updated on Thursday, January 29, 2015 - 2:28pm